CLIA Hot Topics CLIA Gary Yamamoto

Slides:



Advertisements
Similar presentations
JCAHO –A HIPAA Business Associate National HIPAA Summit
Advertisements

Long Term Care Provider Associations Meeting Sharon White CMS – Region V August 22, 2007 F314 – Pressure Ulcers.
2014 Edition Release 2 EHR Certification Criteria Final Rule.
Karen M. Fuller Centers for Medicare & Medicaid Services
Presentation before the Missouri Bar’s Health and Hospital Law Committee November 18, 2011 Markus P. Cicka, J.D., L.L.M. (Health Law) Director – Missouri.
COMPLYING WITH HIPAA PRIVACY RULES Presented by: Larry Grudzien, Attorney at Law.
CLIA-Waiver What is CLIA?
4/30/20151 Quality Assurance Overview. 4/30/20152 Quality Assurance System Overview FY 04/05- new Quality Assurance tools implemented, taking into consideration.
MLAB 2401: C LINICAL C HEMISTRY K ERI B ROPHY -M ARTINEZ Point of Care Testing 1.
New Staff Orientation1 SURVEY AND CERTIFICATION 101 Tracey B. Mummert, MT (ASCP) Special Assistant CMSO, Survey and Certification Group.
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
Telemedicine Credentialing and Privileging October 16, 2014.
New Staff Orientation 1 CMS Role of the State Agency Role of the Surveyor Stephanie Senior, RN Branch Manager, Survey Region 2. New York.
FY14 Contract Training for Public Health Prenatal Program/Maternity Services Trina Miller Prenatal Program Coordinator Division of Child & Family Health.
CBER Blood Establishment Registration and Product Listing Jan O’Brien Blood Registration Coordinator DBA, OBRR, CBER September 15, 2009.
Implementing and Enforcing the HIPAA Privacy Rule.
Medicaid Hospital Utilization Review and DRG Audits: Frequently Asked Questions The Department of Medical Assistance Services Division of Program Integrity.
Proposed Rules to Help Ensure the Safety of Imported Food 1.
CLIA COMPLIANCE. What is CLIA? In 1988 Congress turned its attention to deficiencies in the quality of services provided by the nation’s laboratories.
ANC Bylaws Amendments July 22, Article III Membership B Membership Criteria, p. 2 “Neighborhood Group” shall mean a Homeowners Association or.
Establishing a Hospital Patient
The Post-Survey Process George Mason University College of Nursing and Health Science Regulatory Requirements for Health Systems Summer 2004 Used with.
DSDS Quality Assurance Unit State of Alaska, Dept. of Health and Social Services Division of Senior and Disabilities Services (DSDS) Quality Assurance.
1 State of Michigan Department of Community Health Bureau of Health Systems Division of Operations Roxanne Perry February 28, 2008.
Computerized Networking of HIV Providers Workshop Data Security, Privacy and HIPAA: Focus on Privacy Joy L. Pritts, J.D. Assistant Research Professor Health.
Agency Drafts Statement of Scope Governor Approves Statement of Scope (2) No Agency Drafts: Special Report for rules impacting housing
IRB Board Education Session 6 How Consent Regulations are Implemented in INSPIR Mary Banks Director, Office of the IRB June -July 2005.
1 Supplemental Regulations to 34 CFR Part 300 Assistance to States for the Education of Children with Disabilities and Preschool Grants for Children with.
© Copyright, The Joint Commission The Joint Commission: Deeming Authority and the Integrated Survey Process for Psychiatric Hospitals and the Special Conditions.
Presented by: Yolanda Chavez, RN, BSN Policy Rules and Curriculum Development Unit DADS Regulatory Services 1 DADS REGULATORY UPDATE March 2013.
New York State Health Homes Implementation and Billing Update Statewide Webinar Presented by: New York State Department of Health January 12,
Accounting for Electronic Health Record Payments July 25, 2012 Draffin & Tucker, LLP
CLIA Final Regulation Judy Yost Director, Division of Laboratory Services CMS.
Privacy and Confidentiality. Definitions n Privacy - having control over the extent, timing, and circumstances of sharing oneself (physically, behaviorally,
2008 SPCC Rule Amendments 2008 SPCC Rule Amendments Donald P Smith US Environmental Protection Agency Region VI May, 2009 Current Status.
Introduction to the Clinical Laboratory
Michigan Department of Community Health Bureau of Health Systems Mike Pemble Director Joint Provider Surveyor Training September 14, 2010.
OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.
Guidance Training CFR §483.75(i) F501 Medical Director.
Guidance Training (F520) §483.75(o) Quality Assessment and Assurance.
EMTALA Technical Advisory Group (TAG) Update David Siegel, M.D., J.D., FACEP, FACP Chair.
Investigational Devices and Humanitarian Use Devices June 2007.
Home Health Face-to-Face Encounter Adapted from Presentations of National Association for Home Care & Hospice and Home Care Association of Washington by.
Ambulatory Surgery Centers NY Metro ASC Symposium October 15,
Mammography Regulations and Standards in the U.S.: The Basics of the Mammography Quality Standards Act Helen J. Barr, MD Director, Division of Mammography.
OMB Circular A-122 and the Federal Cost Principles Copyright © Texas Education Agency
Community Development Department Pain Management Clinics Potential Local Regulations City Council Workshop September 13, 2011.
Introduction to Quality Assurance. Quality assurance vs. Quality control.
Crouse Health Hospital
Proposed Medicaid Hospital Outpatient Prospective Payment System
The HIPAA Privacy Rule: Implications for Medical Research
Investigator of Record – Definition
FDA’s IDE Decisions and Communications
Updates to Expedited Review Procedures
Public Comment Webinars January 14, 2015 and January 15, 2015
Laws Relating to Accreditation, the use of NGABs, and Enforcement
CLIA Hot Topics CLIA Gary Yamamoto
Overview of Important Changes to the Final Rule
Updates to Expedited Review Procedures
Investigator of Record – Definition
Investigator of Record – Definition
Secondary Research with Identifiable Information and Biospecimens
Overview of Important Changes to the Final Rule
Safety and Regulatory Guidelines In the Medical Laboratory
Emergency Preparedness Requirements
What is OAL? The Office of Administrative Law (OAL) ensures that agency regulations are clear, necessary, legally valid, and available to the public. OAL.
Recommended Changes to the Commonwealth’s COPN Laws
The Revised Common Rule
Research Operations and Lab Services
Presentation transcript:

CLIA Hot Topics CLIA Gary Yamamoto Centers for Medicare & Medicaid Services San Francisco Regional Office CLIA

STATISTICS CLIA Certification Certificates Region IX Nation Waived 22,171 73% 181,270 71% PPMP 4,311 14% 36,255 Compliance 2,073 7% 19,553 8% Accreditation 1,712 6% 16,683 TOTAL 30,267 253,761 CLIA

STATISTICS Self-Determined Laboratory Types Region IX Nation POL 50% 48% Pharmacy 4% Nursing Facility 6% Home Health Agency Hospital 3% Community Clinic Independent 2% CLIA

STATISTICS CLIA Certification - POL Certificates Nation Waived 72,131 61% PPMP 29,017 24% Compliance 12,289 10% Accreditation 5,856 5% TOTAL 119,293 CLIA

STATISTICS CLIA Certification of Accreditation Organization Nation COLA 44% CAP 39% TJC 15% AABB 1% ASHI 0.4% AOA 0.6% CLIA

IQCP CLIA Individualized Quality Control Plan (IQCP) Replaces Equivalent Quality Control (EQC) CLIA

IQCP CLIA Pursuant to 42 CFR § 493.1256(d): Unless CMS approves a procedure specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must. . .” CLIA

IQCP Facts Education and transition period started on January 1, 2014 On January 1, 2016, laboratories must be in compliance with their quality control choice or deficiencies will be cited CLIA

IQCP Policies Applies to CMS-certified, non-waived laboratories, covering all phases of the testing process May or may not reduce QC amount or frequency IQCP is optional; default is regulations CLIA

IQCP Education and Transition Period CLIA certified laboratories should: Continue to follow existing quality control protocols Decide to implement IQCP or default quality control Plan and complete their transition accordingly, phasing out EQC, if applicable CLIA

IQCP Educational Outreach Brochure 11: CLIA Individualized Quality Control Plan Introduction Brochure 12: Considerations When Deciding to Develop an IQCP Brochure 13: What is IQCP? CLIA

IQCP Educational Outreach CMS, in collaboration with the CDC, released the IQCP Workbook Geared primarily towards physician office laboratories (POL) and other smaller laboratories CLIA

CLIA Interpretive Guidelines Revised guidelines published on the CLIA website January 9, 2015 Summary of major changes included in S&C Memo 15-17-CLIA January 2016 revision: Removal of EQC Addition of IQCP CLIA

CLIA Interpretive Guidelines Removal of CLSI Microbiology References For the following requirements, references to CLSI documents have been removed: 42 C.F.R. § 493.1256(e)(4) [Media QC] 42 C.F.R. § 493.1261(b)(1 – 2) [Susceptibility] For additional information, refer to S&C Memo 15-07-CLIA CLIA

CLIA Interpretive Guidelines Removal of CLSI Microbiology References With the 01/09/2015 publication of the revised IG, microbiology laboratories will have 2 options for CLIA quality control: Follow all applicable CLIA quality control regulations Implement IQCP CLIA surveyors will cite laboratories for non-compliance CLIA

TEST Act – HR 6118 TEST Act – Taking Essential Steps for Testing Act of 2012 Amendment to the CLIA statute signed by the President on December 4, 2012 Clarifies that proficiency testing samples to be tested in the same manner as patient specimens, EXCEPT that no proficiency testing samples shall be sent to another laboratory for analysis CLIA

TEST Act – HR 6118 Allows the Secretary enforcement discretion for: Revocation of a laboratory’s CLIA certificate for proficiency testing referral Imposition of the 2-year owner/operator prohibition when the laboratory is sanctioned for proficiency testing referral CLIA

TEST Act – HR 6118 Regulations required to implement the TEST Act published May 2, 2014, and effective July 1, 2014 Final rule details hierarchical adverse actions for proficiency testing referrals by seriousness Defines when discretion will be applied and when revocation will be imposed CLIA

TEST Act – HR 6118 Adds definition to 42 CFR § 493.2 for “repeat” proficiency testing referral A second instance in which a proficiency testing sample, or a portion of a sample, is referred, for any reason, to another laboratory for analysis prior to the laboratory’s proficiency testing program event cut-off date within the period of time encompassing the two prior survey cycles. Applies to all CLIA certificate types CLIA

Proficiency Testing Referral Category 1 Repeat PT referral or laboratory sends PT samples to another laboratory and reports that laboratory’s test results as it’s own CMS must impose: Revocation of the laboratory’s CLIA certificate Civil Money Penalty (CMP) CMS may impose: Owner prohibition Includes a provision for discretion in exempting the owner from the prohibition CLIA

Proficiency Testing Referral Category 2 Laboratory sends PT samples or the results of PT samples to another laboratory prior to, or on, the event cut-off date Referring laboratory reports its own PT sample results CMS must impose: Suspension/Limitation of the laboratory’s CLIA certificate Civil Money Penalty (CMP) Directed Plan of Correction CMS may impose: Any other alternative sanctions, as appropriate CLIA

Proficiency Testing Referral Category 3 Laboratory sends PT samples to another laboratory but no test results were receveid prior to the event cut-off date CMS must impose: Civil Money Penalty (CMP) Directed Plan of Correction CMS may impose: Any other alternative sanctions, as appropriate CLIA

Proficiency Testing Referral Narrow Exception One-time, narrow exception carve-out for intentional PT referral Clarifies intentional PT referral carve-out with addition of the following terms/definitions: Reflex testing Confirmation testing Distributive testing CLIA

Proficiency Testing Referral Narrow Exception CMS will consider the referral to be improper and subject to alternative sanctiosn in accordance with 42 CFR 493.1804© but not intentional if: Not a repeat proficiency testing referral Limited to reflex, confirmatory, or distributive testing CLIA

Proficiency Testing Referral Narrow Exception CMS will consider the referral to be improper, but not intentional, and subject to alternative sanctions in accordance with 42 CFR § 493.1804(c): If the referral is not a repeat proficiency testing referral It the referral is limited to reflex, confirmatory, or distributive testing If the sample was a patient specimen, the referral would have been in full conformance with written, legally accurate and adequate standard operating procedures for the laboratory’s testing of patient specimens CLIA

Proficiency Testing Referral Narrow Exception Reflex Testing Confirmatory or additional laboratory testing that is automatically requested by a laboratory under its standard operating procedures for patient specimens when the laboratory’s findings indicate test result that are abnormal, are outside a predetermined range, or meet other pre-established criteria for additional testing CLIA

Proficiency Testing Referral Narrow Exception Confirmatory Testing Testing performed by a second analytical procedure that could be used to substantiate or bring into question the results of an initial laboratory test CLIA

Proficiency Testing Referral Narrow Exception Distributive Testing Laboratory testing performed on the same specimen, or an aliquot of it, that requires sharing it between two or more laboratories to obtain all data required to complete an interpretation or calculation necessary to provide a final reportable result for the originally ordered test When such testing occurs at multiple locations with different CLIA certificates, it is considered distributive testing CLIA

CLIA CLIA CLIA information can be found at the CMS Website: www.cms.gov/clia IQCP Mailbox: IQCP@cms.hhs.gov CLIA Interpretive Guidelines Mailbox: CLIA_IG@cms.hhs.gov CLIA